P&G Health Q4 Profit Jumps 31% to Rs 61 cr
x
P&G Health India announces a 31% surge in net profit to Rs 61 crore for the March quarter, driven by strong brand building and improved supply chain. Sales also saw significant growth.
New Delhi, Jun 5 (PTI) Procter & Gamble Health Ltd on Thursday said its net profit jumped 31 per cent to Rs 61 crore in the January-March quarter.
Net sales for the quarter rose 23 per cent to Rs 304 crore over the same period of the last year, P&G Health said in a statement.
Financial performance was boosted by superior brand-building activities and supported by strengthened supply chain and go-to-market capabilities, it said.
P&G Health also announced that it has changed its financial year from July 1-June 30 to April 1- March 31.
The current financial year of the company covers a period of 9 months, from July 1, 2024, to March 31, 2025.
For the nine-month fiscal year ended March 31, 2025, the company recorded sales of Rs 918 crore, up 8 per cent compared to the same nine-month period a year ago. For the period under review, the reported profit after tax stood at Rs 234 crore, up 27 per cent against the comparable nine-month period a year ago.
Milind Thatte, Managing Director, P&G Health India, said, "This was a period of purposeful transformation and acceleration. We invested in initiatives to address the changing needs of our consumers and healthcare professionals, while strengthening our go-to-market and supply chain capabilities."
The company said its board has recommended a final dividend of Rs 45 per share for the financial year ending March 31, 2025, subject to the approval of the shareholders.
Net sales for the quarter rose 23 per cent to Rs 304 crore over the same period of the last year, P&G Health said in a statement.
Financial performance was boosted by superior brand-building activities and supported by strengthened supply chain and go-to-market capabilities, it said.
P&G Health also announced that it has changed its financial year from July 1-June 30 to April 1- March 31.
The current financial year of the company covers a period of 9 months, from July 1, 2024, to March 31, 2025.
For the nine-month fiscal year ended March 31, 2025, the company recorded sales of Rs 918 crore, up 8 per cent compared to the same nine-month period a year ago. For the period under review, the reported profit after tax stood at Rs 234 crore, up 27 per cent against the comparable nine-month period a year ago.
Milind Thatte, Managing Director, P&G Health India, said, "This was a period of purposeful transformation and acceleration. We invested in initiatives to address the changing needs of our consumers and healthcare professionals, while strengthening our go-to-market and supply chain capabilities."
The company said its board has recommended a final dividend of Rs 45 per share for the financial year ending March 31, 2025, subject to the approval of the shareholders.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone-Idea
- 11.36 ( -2.49)
- 94664837
- AvanceTechnologies
- 1.16 (+ 4.50)
- 34522155
- Sunshine-Capital
- 0.26 ( -3.70)
- 29015901
- Alstone-Textiles
- 0.27 ( -3.57)
- 28695959
- Mehai-Technology
- 1.65 ( -4.62)
- 28262795






